An approach to prevent the severe adverse events associated with transfusion of FDA-approved blood products

Transfusion and Apheresis Science

Volumn 42, Issue 3, 2010, Pages 223-233

  Valeri, C Robert ^a   Ragno, Gina ^a  

^a NBRL Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOSTATIC AGENT; BLOOD SUBSTITUTE;

ACUTE LUNG INJURY; ANEMIA; ARTICLE; BLEEDING; BLOOD STORAGE; BLOOD SUBSTITUTION; BLOOD TRANSFUSION; CRYOPRESERVATION; ERYTHROCYTE; FOOD AND DRUG ADMINISTRATION; FUNCTIONAL ASSESSMENT; HEMOSTASIS; HUMAN; MORBIDITY; MORTALITY; PLASMA TRANSFUSION; RESUSCITATION; RISK REDUCTION; SURVIVAL TIME; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; DRUG APPROVAL; ERYTHROCYTE TRANSFUSION; STANDARDS; TIME; UNITED STATES;

ACUTE LUNG INJURY; BLOOD PRESERVATION; BLOOD SUBSTITUTES; DRUG APPROVAL; ERYTHROCYTE TRANSFUSION; HEMOSTATICS; HUMANS; PLATELET TRANSFUSION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME FACTORS; UNITED STATES;

EID: 77953026125     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2009.08.001     Document Type: Article

References (82)

1. Valeri C.R., and Ragno G. Cryopreservation of human blood products. Trans Apher Sci 34 (2006) 271-287 [with an editorial on p. 267-9]
2. Lelkens C.C.M., Koning J.R., deKort B., Floot I.B.G., and Noorman F. Experience with frozen blood products in the Netherlands military. Trans Apher Sci 34 (2006) 289-296
3. Zimrin A.B., and Hess J.R. Current issues relating to the transfusion of stored red blood cells. Vox Sang 96 (2009) 93-103
4. Lelubre C., Piagnerelli M., and Vincent J.L. Association between duration of storage of transfused red blood cells and morbidity and mortality in adult patients: myth or reality?. Transfusion 49 (2009) 1384-1394
5. Bennett-Guerrero E., Stafford-Smith M., Waweru P.M., Bredehoeft S., Campbell M.L., Haley N.R., et al. A prospective, double-blind, randomized clinical feasibility trial of controlling the storage age of red blood cells for transfusion in cardiac surgical patients. Transfusion 49 (2009) 1375-1383
6. Steiner M.E., and Stowell C. Does red blood cells storage affect clinical outcome? When in doubt, do the experiment. Transfusion 49 (2009) 1286-1290
7. Basran S., Frumento R.J., Cohen A., Lee S., Du Y., Nishanian F., et al. The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery. Anesth Analg 100 (2006) 15-20
8. Koch C.G., Li L., Sessler D.I., et al. Duration of red cell storage and complications after cardiac surgery. N Engl J Med 358 (2008) 1229-1239
9. Valeri C.R. Measurement of viable ADSOL-preserved human red blood cells. N Eng J Med 312 (1985) 377-378
10. Valeri C.R., Pivacek L.E., Palter M., Dennis R.C., Yeston N., Emerson C.P., et al. A clinical experience with ADSOL® preserved erythrocytes. Surg Gynec Obstet 166 (1988) 33-46
11. Valeri C.R. Status report on the quality of liquid and frozen red blood cells. Vox Sang 83 1 (2002) 193-196
12. McFaul S.J., Corley J.B., Mester C.W., and Nath J. Packed blood cells stored in AS-5 become proinflammatory during storage. Transfusion 49 (2009) 1451-1460
13. Biffi W.L., Moore E.E., Offner P.J., Ciesla D.J., Gonzalez R.J., and Silliman C.C. Plasma from aged stored red blood cells delays neutrophil apoptosis and primes for cytotoxicity: abrogation by poststorage washing but not prestorage leukoreduction. J Trauma 50 (2001) 426-432
14. Adamson J.W. Editorial new blood, old blood or no blood?. N Engl J Med 358 (2008) 1295-1296
15. Dzik W. Fresh blood for everyone? Balancing availability and quality of stored RBCs. Transfus Med 18 (2008) 260-268
16. Valeri C.R. Physiology of blood transfusion. In: Barie P.S., and Shires G.T. (Eds). Surgical intensive care (1993), Little, Brown & Co. 681-721
17. Maegele M., Lefering R., Paffrath T., Tjardes T., Simanski C., Bouillon B., et al. Red blood cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiple injury: a retrospective analysis from the Trauma Registry of the Deutsche Gessellschaft fur Unfallchirurgie. Vox Sang 95 (2008) 112-119
18. Hess J.R., Dutton R.B., Holcomb J.B., and Scalea T.M. Giving plasma at a 1:1 ratio with red cells in resuscitation: who might benefit?. Transfusion 48 (2008) 1763-1765
19. Valeri C.R., Khuri S., and Ragno G. Non-surgical bleeding diathesis in anemic thrombocytopenic patients: role of temperature, RBC, platelets, and plasma clotting proteins. Transfusion 47 (2007) 206S-248S
20. Heaton A., Keegan T., and Holme S. In vivo regeneration of red cell 2,3-diphosphoglycerate following transfusion of DPG-depleted AS-1, AS-3 and CPDA-1 red cells. Br J Haematol 71 (1989) 131-136
21. Valeri C.R., and Hirsch N.M. Restoration in vivo of erythrocyte adenosine triphosphate, 2,3-diphosphoglycerate, potassium ion, and sodium ion concentrations following the transfusion of acid-citrate-dextrose-stored human red blood cells. J Lab Clin Med 73 (1969) 722-733
22. Beutler E., and Wood L. The in vivo regulation of red cells 2,3 diphosphoglyceric acid (DPG) after transfusion of stored blood. J Lab Clin Med 74 (1969) 300-304
23. Valeri CR. Oxygen transport function of preserved red cells. In Garby L, editor. Clinics in haematology, anaemia and hypoxia, vol. 3, no. 3. Philadelphia, London: Saunders; 1974. p. 649-88.
24. Valeri C.R. Clinical importance of the oxygen transport function of preserved red blood cells. In: Nicolau C. (Ed). Proceedings of the 12th Katzir-Katchalsky meeting on oxygen transport in red blood cells, 4-7 April 1984, Tours, France (1986), Pergamon Press, Oxford, England
25. Weiskopf R.B., Feiner J., and Toy P. Red cell age and function. Transfusion 48 (2008) 2026
26. Valeri C.R., Rorth M., Zaroulis C.G., Jakubowski M.S., and Vescera S. Physiologic effects of hyperventilation and phlebotomy in baboons: systemic and cerebral oxygen extraction. Ann Surg 181 (1975) 99-105
27. Valeri C.R., Rorth M., Zaroulis C.G., Jakubowski M.S., and Vescera S. Physiologic effects of transfusing red blood cells with high or low affinity for oxygen to passively hyperventilated, anemic baboons: systemic and cerebral oxygen extraction. Ann Surg 181 (1975) 106-113
28. Valeri C.R., MacGregor H., Giorgio A., and Ragno G. Circulation and hemostatic function of autologous fresh, liquid preserved, and cryopreserved baboon platelets transfused to correct an aspirin-induced thrombocytopathy. Transfusion 42 (2002) 1206-1216
29. Khuri S.F., Healey N., MacGregor H., Barnard M.R., Szymanski I.O., Birjiniuk V., et al. Comparison of the effects of transfusions of cryopreserved and liquid-preserved platelets on hemostasis and blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg 117 (1999) 172-184
30. Handin R.I., and Valeri C.R. Hemostatic effectiveness of platelets stored at 22 °C. N Eng J Med 285 (1971) 538-543
31. Valeri C.R. Hemostatic effectiveness of liquid-preserved and previously frozen human platelets. N Eng J Med 290 (1974) 353-358
32. Valeri C.R., Feingold H., and Marchionni L.D. A simple method for freezing human platelets using 6% dimethylsulfoxide and storage at -80 °C. Blood 43 (1974) 131-136
33. Melaragno A.J., Carciero R., Feingold H., Talarico L., Weintraub L., and Valeri C.R. Cryopreservation of human platelets using 6% dimethylsulfoxide and storage at -80 °C. Effects of 2 years of frozen storage at -80 °C and transportation in dry ice. Vox Sang 49 (1985) 245-258
34. Valeri C.R., Ragno G., and Khuri S. Freezing human platelets using 6% DMSO with removal of the supernatant solution prior to freezing and storage at -80 °C without post-thaw processing. Transfusion 45 12 (2005) 1890-1898
35. Hornsey V.S., McMillan L., Morrson A., Drummon O., MacGregor I.R., and Prowse C.V. Freezing of buffy coat-derived, leukoreduced platelet concentrates in 6 percent dimethyl sulfoxide. Transfusion 48 (2008) 2508-2514
36. Moss G.S., Valeri C.R., and Brodine C.E. Clinical experience with the use of frozen blood in combat casualties. N Eng J Med 278 (1968) 748-752
37. Valeri C.R., Valeri D.A., Anastasi J., Vecchione J.J., Dennis R.C., and Emerson C.P. Freezing in the primary polyvinylchloride plastic collection bag: a new system for preparing and freezing nonrejuvenated and rejuvenated red blood cells. Transfusion 21 (1981) 138-149
38. Leal-Noval S.R., Jara-Lopez I., Garcia-Carmendia J.L., et al. Influence of erythrocyte concentrate storage time on postsurgical morbidity in cardiac surgery patients. Anesthesiology 98 (2003) 512-522
39. Kuduvalli M., Oo A.Y., Newall N., et al. Effect of perioperative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery. Eur J Cardiothorac Surg 27 (2005) 592-598
40. Tinmouth A., Ferguson D., Ye I.C., and Hebert P.C. Clinical consequence of red cell storage in the critically ill. Transfusion 46 (2006) 2014-2027
41. International Forum. Measures to prevent TRALI. Vox Sang 92 (2007) 258-277
42. Valeri C.R., and Ragno G. Prevention of TRALI. Vox Sang 94 (2008) 81
43. Valeri C.R., and Ragno G. The effects of preserved red blood cells on the severe adverse events observed in patients infused with hemoglobin based oxygen carriers. Artif Cells Blood Substit Biotechnol 36 1 (2008) 3-18
44. Bennett-Guerrero B., Veldman T.H., Doctor A., Telen M.J., Ortel T.L., Reid T.S., et al. Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci 104 (2007) 17063-17068
45. Valeri C.R., and Ragno G. Role of nitric oxide in the prevention of severe adverse events associated with blood products. Trans Apher Sci 39 (2008) 241-245
46. Valeri C.R. Blood banking and the use of frozen blood products (1976), Chemical Rubber Company, Boca Raton, FL
47. Natanson C., Kern S.H., Lurie P., et al. Cell-free hemoglobin-based blood substitute and risk of myocardial infarction and death: a metaanalysis. JAMA 299 (2008) 2304-2312
48. Valeri C.R. Viability and function of preserved red cells. N Eng J Med 284 (1971) 81-88
49. Vogel W.M., Dennis R.C., Cassidy G.P., Apstein C.S., and Valeri C.R. Coronary constrictor effect of stroma-free hemoglobin solutions. Am J Physiol 251 Heart Circ Physiol 20 (1986) H413-H420
50. Valeri C.R., Ragno G., and Veech R.L. Effects of the resuscitation fluid and the HBOC excipient on the toxicity of the HBOC: Ringer's d,l-lactate, Ringer's l-lactate, and Ringer's ketone solutions. Artif Cells Blood Substit Biotechnol 34 6 (2006) 601-606
51. Valeri C.R., Ragno G., and Veech R.L. Severe adverse events associated with hemoglobin based oxygen carriers: role of resuscitative fluids and liquid preserved RBC. Trans Apher Sci 39 (2008) 205-211
52. Hess J.R. Review of blood substitutes. In: Winslow R.M. (Ed). Transfus Med Rev 20 (2006) 247-248
53. Chang T.M.S. Editorial: safety of red blood cell substitutes as compared to stored donor red blood cells. Artif Cells Blood Substit Biotechnol 36 (2008) 1-2
54. Estep T., Bucci E., Farmer M., Greenburg G., Harrington J., Kim H.W., et al. Basic science focus on blood substitutes: a summary of the NHLBI Division of Blood Diseases and Resources Working Group Workshop, March 1, 2006. Transfusion 48 (2008) 776-782
55. McCord J.H. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312 (1985) 159-163
56. Faller M.S., Hoidal J.R., and Ferris P.T. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 74 (1984) 1156-1164
57. Lieberthal W., Fuhro R., Andry C., and Valeri C.R. Effects of hemoglobin-based oxygen-carrying solutions in anesthetized rats with acute ischemic renal failure. J Lab Clin Med 135 (2000) 73-81
58. Fan H., Sun B., Gu Q., et al. Oxygen radicals trigger activation of NF-kB and AP-1 and upregulation of ICAM-1 in reperfused canine heart. Am J Physiol Heart Circ Physiol 282 (2002) H1778-H1786
59. Thirunavukkarasu C., Watkins W., Harvey S.A.K., and Gandhi C. Superoxide-induced apoptosis of activated rat hepatic stellate cells. J Hepatol 41 (2004) 567-579
60. Higuchi M., Manna S.K., Sasaki R., and Aggarwal B.B. Regulation of the activation of nuclear factor kappa B by mitochondrial respiratory function: evidence for the reactive oxygen species-dependent and independent pathways. Antioxid Redox Signal 4 (2002) 945-950
61. Fransen E., Maessen J.G., Dentener M., Senden N., and Buurman W. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest 116 (1999) 1233-1239
62. Dunne J.R., Malone D.L., Tracy J.K., and Napolitano L.M. Allogeneic blood transfusion in the first 24 hours after trauma is associated with systemic inflammatory response syndrome (SIRS) and death. Surg Infect 5 (2004) 395-404
63. Malone D.L., Dunne J., Tracy J.K., Putnam A.T., Scalea T.M., and Napolitano L.M. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 54 (2003) 898-905
64. Valeri C.R., and Zaroulis C.G. Rejuvenation and freezing of outdated stored human red cells. N Eng J Med 287 (1972) 1307-1313
65. Valeri C.R. Use of rejuvenation solutions in red blood cell preservation. CRC Crit Rev Clin Lab Sci 17 (1982) 299-374
66. Valeri C.R., Sims K.L., Bates J.F., Reichman D., Lindberg J.R., and Wilson A.C. An integrated liquid-frozen blood banking system. Vox Sang 45 (1983) 25-39
67. Valeri C.R., Pivacek L.E., Gray A.D., Cassidy G.P., Leavy M.E., Dennis R.C., et al. The safety and therapeutic effectiveness of human red cells stored at -80 °C for as long as 21 years. Transfusion 29 (1989) 429-437
68. Valeri C.R., Pivacek L.E., Cassidy G.P., and Ragno G. The survival, function, and hemolysis of human RBCs stored at 4 °C in additive solution (AS-1, AS-3, or AS-5) for 42 days and then biochemically modified, frozen, thawed, washed, and stored at 4 °C in sodium chloride and glucose solution for 24 hours. Transfusion 40 (2000) 1341-1345
69. Valeri C.R., Ragno G., and Popovsky M.A. Red cell freezing and its impact on the supply chain. [Letter to the Editor]. Transfus Med 14 (2004) 1-2
70. Ragno G., and Valeri C.R. Salvaging of liquid-preserved O-positive and O-negative red blood cells by rejuvenation and freezing. Trans Apher Sci 35 (2006) 137-143
71. Valeri C.R., Ragno G., Pivacek L.E., Srey R., Hess J.R., Lippert L.E., et al. A multicenter study of in vitro and in vivo values in human RBCs frozen with 40-percent (wt/vol) glycerol and stored after deglycerolization for 15 days at 4 °C in AS-3: assessment of RBC processing in the ACP 215. Transfusion 41 (2001) 933-939
72. Valeri C.R., Ragno G., Pivacek L.E., and O'Neill E.M. In vivo survival of apheresis RBCs, frozen with 40-percent (wt/vol) glycerol, deglycerolized in the ACP 215, and stored at 4 °C in AS-3 for up to 21 days. Transfusion 41 (2001) 928-932
73. Valeri C.R., and Ragno G. Automation of the glycerolization of the RBC using the high separation bowl in the Haemonetics ACP215 instrument. Transfusion 45 10 (2005) 1621-1627
74. Bandarenko N., Hay S.N., Holmberg J., Whiteley P., Taylor H.L., Moroff G., et al. Extended storage of AS-1 and AS-3 leukoreduced red blood cells for 15 days after deglycerolization and resuspended in AS-3 using an automated closed system. Transfusion 44 (2004) 1656-1662
75. Bandarenko N., Cancelas J.A., Snyder E., Hay S.N., Rugg N., Corda T., et al. Successful in vivo recovery and extended storage of AS-5 red blood cells following deglycerolization and resuspension in AS-3 for 15 days using an automated closed system. Transfusion 47 (2007) 680-686
76. Grose H.L., Byrne K.M., Sanata J.M., Rentas P.L., and Stroncel D.E. In vitro variables of red blood cell components collected by apheresis and frozen 6 and 14 days after collection. Transfusion 46 (2006) 1178-1183
77. Valeri C.R., and Altschule M.D. Hypovolemic anemia of trauma: the missing blood syndrome (1981), Chemical Rubber Company, Boca Raton, FL
78. Noorman F., Streliski R., and Lelkens C.C. Frozen -80 °C red cells, plasma and platelets in combat casualty care. Transfusion 49 3S (2009) 26A [Supplement]
79. Szymanski I.O., and Valeri C.R. Clinical evaluation of concentrated red cells. N Eng J Med 280 (1969) 281-287
80. Valeri C.R., Szymanski I.O., and Zaroulis C.G. 24-Hour survival of ACD- and CPD-stored red cells. I. Evaluation of nonwashed and washed stored red cells. Vox Sang 2 (1972) 289-308
81. Valeri C.R., Gray A.D., Cassidy G.P., Riordan W., and Pivacek L.E. The 24-hour posttransfusion survival, oxygen transport function, and residual hemolysis of human outdated-rejuvenated red cell concentrates after washing and storage at 4 °C for 24 to 72 hours. Transfusion 24 (1984) 323-326
82. Grahmer C., Holmberg J., Popovsky M., Amann E., Schonitzer D., Falaize S., et al. Up to 21-day banked red blood cells collected by apheresis and stored for 14 days after automated washed at different times of storage. Vox Sang 90 (2006) 40-44